The DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
Open accessAbstract
Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein particles implicated in this disorder remain ill defined. We determined the qualitative and quantitative characteristics of the density distribution of low density lipoprotein (LDL) particle subspecies in nine subjects defined phenotypically as presenting CHL, and under strict dietary control. Seven CHL patients possessed familial antecedents of premature coronary heart disease; none were E2E2 homozygotes. Five LDL subspecies were isolated by density gradient ultracentrifugation in the density range 1.019-1.063 g/ml. In all patients, the LDL profile was skewed towards the dense subspecies (LDL-4, d 1.039-1.050 g/ml and LDL-5, d 1.050-1.063 g/ml), representing 47% of total LDL mass; by contrast, these subspecies accounted for only 30% of LDL mass in five normolipidemic subjects (P < 0.01). In addition, plasma LDL mass concentrations were some twofold higher in CHL patients as compared to normolipidemic subjects. The % mass of LDL-4 was positively correlated with plasma triglyceride and apoB levels. LDL-2 and LDL-3 in CHL patients were triglyceride-enriched (11.9 and 7.2%, respectively) as compared to the corresponding subspecies in normolipidemic subjects (6.6 and 3.7%, respectively; P < 0.05 in each case). LDL particle size decreased with increase in density in both groups; however, significant differences were found between corresponding LDL subspecies (LDL-1, -3, -4, and -5) in CHL patients and normolipidemic subjects, a finding suggestive of dissimilar molecular organization, despite correspondence in hydrated density. The copper-induced oxidative modification of LDL subspecies was assessed by determination of conjugated diene formation. In both groups, LDL-5 was distinct in exhibiting a marked diminution in oxidative resistance as indicated by a significant reduction (P < 0.01) in mean lag time. The oxidative susceptibility of LDL subspecies in both groups was independent of vitamin E content when expressed as the ratio vitamin E/LDL mass, although dense LDL in CHL patients tended to be deficient in this antioxidant. The diminished oxidative resistance of dense LDL subspecies could not be accounted for by enrichment in polyunsaturated fatty acids in either group. These studies suggest that in consequence of their elevated circulating concentration and diminished oxidative resistance, dense LDL subspecies represent putative atherogenic subspecies in combined hyperlipidemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Larger LDL particles may reduce CV risk because small dense LDL is associated with increased atherogenicity [55].”
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Enzymatic determination of total serum cholesterol.
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,693
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
Research works printed but not linked: 2
- Steinberg, 1989, Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915
- Esterbauer, 1989, Continuous monitoring of in vitro oxidation of human low density lipoprotein, Free Rod. Res. Commun., 6, 67
Cited by
Sorted by citations
Items 101–200 of 237
Genetic and environmental influences on LDL subclass phenotypes
Austin, M. A. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04204.x · Cited by 37
Froyen, E. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01501-0 · Cited by 38
Ohta, T., Nishiyama, S., Nakamura, T., Saku, K., Maung, K. K., & Matsuda, I. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050810 · Cited by 35
Granér, M., Kahri, J., Nakano, T., Sarna, S. J., Nieminen, M. S., Syvänne, M., & Taskinen, M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01720.x · Cited by 35
Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects
Cassader, M., Gambino, R., Ruiu, G., Marena, S., Bodoni, P., & Pagano, G. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339605 · Cited by 35
Cuchel, M., Schwab, U., Jones, P. J. H., Vogel, S., Lammi‐Keefe, C. J., Li, Z., Ordovás, J. M., McNamara, J. R., Schaefer, E. J., & Lichtenstein, A. H. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90061-x · Cited by 35
Clinical significance of the physicochemical properties of LDL in type 2 diabetes
Scheffer, P. G., Teerlink, T., & Heine, R. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1736-0 · Cited by 34
Yoshino, G., Hirano, T., & Kazumi, T. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.266 · Cited by 33
Crystallization and Preliminary X-ray Analysis of a Low Density Lipoprotein from Human Plasma
Prassl, R., Chapman, J., Nigon, F., Sára, M., Eschenburg, S., Betzel, C., Saxena, A. K., & Laggner, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28731 · Cited by 33
Schwab, U., Ausman, L. M., Vogel, S., Li, Z., Lammi‐Keefe, C. J., Goldin, B. R., Ordovás, J. M., Schaefer, E. J., & Lichtenstein, A. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00310-x · Cited by 32
Durrington, P. N. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0019 · Cited by 31
Rufail, M. L., Schenkein, H. A., Barbour, S. E., Tew, J. G., & van Antwerpen, R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500389-jlr200 · Cited by 31
Microphase Separation in Low Density Lipoproteins
Pregetter, M., Prassl, R., Schuster, B., Kriechbaum, M., Nigon, F., Chapman, J., & Laggner, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1334 · Cited by 30
Bittolo-Bon, G., & Cazzolato, G. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33353-8 · Cited by 30
Lesnik, P., Dentan, C., Vonica, A., Moreau, M., & Chapman, M. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1121 · Cited by 30
Self-citationHaplotypes of the ApoA-I/C-III/A-IV Gene Cluster and Familial Combined Hyperlipidemia
Tahvanainen, E., Pajukanta, P., Porkka, K., Nieminen, S., Ikävalko, L., Nuotio, I. O., Taskinen, M., Peltonen, L., & Ehnholm, C. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1810 · Cited by 30
Tertov, V. V., Sobenin, I. A., & Orekhov, A. N. (1996) · Free Radical Research · doi:10.3109/10715769609149054 · Cited by 29
Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.
Sniderman, A. D., Bergeron, J., & Frohlich, J. (2001) · Europe PMC (PubMed Central) · Cited by 29
Gómez, P., Pérez‐Martínez, P., Marı́n, C., Camargo, A., Yubero‐Serrano, E. M., García‐Ríos, A., Rodriguez, F., Delgado‐Lista, J., Pérez‐Jiménez, F., & López‐Miranda, J. (2010) · Journal of Nutrition · doi:10.3945/jn.109.115964 · Cited by 29
Golub, M., Lehofer, B., Martínez, N., Ollivier, J., Kohlbrecher, J., Prassl, R., & Peters, J. (2017) · Scientific Reports · doi:10.1038/srep46034 · Cited by 28
Ohta, T., Saku, K., Takata, K., Nagata, N., Maung, K. K., & Matsuda, I. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00163-9 · Cited by 28
Apolipoproteins AI and B as therapeutic targets
Charlton-Menys, V., & Durrington, P. N. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01646.x · Cited by 28
Schwab, U., Vogel, S., Lammi‐Keefe, C. J., Ordovás, J. M., Schaefer, E. J., Li, Z., Ausman, L. M., Gualtieri, L. N., Goldin, B. R., Furr, H. C., et al. (1998) · Journal of Nutrition · doi:10.1093/jn/128.10.1703 · Cited by 28
Lipids, Apolipoproteins and Lipoproteins
Rader, D. J., & Brewer, H. B. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_6 · Cited by 27
Ethier-Chiasson, M., Forest, J., Giguère, Y., Masse, A., Marseille‐Tremblay, C., Levy, E. H., & Lafond, J. (2008) · Reproduction · doi:10.1530/rep-08-0082 · Cited by 27
Low-Density Lipoprotein Particle Size and Its Regulatory Factors in School Children
Shimabukuro, T., Sunagawa, M., & Ohta, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031818 · Cited by 27
Schneider, D. J., & Sobel, B. E. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200506 · Cited by 27
Reaven, P. D., Grasse, B. J., & Barnett, J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1465 · Cited by 27
Antioxidant content in low density lipoprotein and lipoprotein oxidationin vivoandin vitro
Tertov, V. V., Sobenin, I. A., Kaplun, V. V., & Orekhov, A. N. (1998) · Free Radical Research · doi:10.1080/10715769800300191a · Cited by 26
Alterations in lipoprotein defense against oxidative stress in metabolic syndrome
Hansel, B., Kontush, A., Bonnefont‐Rousselot, D., Bruckert, É., & Chapman, M. J. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0026-8 · Cited by 26
Self-citationDiffering α-Tocopherol Oxidative Lability and Ascorbic Acid Sparing Effects in Buoyant and Dense LDL
Tribble, D. L., Thiel, P. M., van den Berg, J. J. M., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.2025 · Cited by 26
Lesnik, P., Dachet, C., Petit, L., Moreau, M., Griglio, S., Brudi, P., & Chapman, M. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.979 · Cited by 26
Self-citationResidual cardiovascular risk among people with diabetes
Dash, S., & Leiter, L. A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13646 · Cited by 27
HDL-C and the diabetic patient: Target for therapeutic intervention?
Rosenson, R. S. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.013 · Cited by 25
Erbey, J. R., Robbins, D. C., Forrest, K. Y. Z., & Orchard, T. J. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90116-6 · Cited by 25
Chen, M.-F., Hsu, H.-C., & Lee, Y. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007722426016 · Cited by 24
Liu, M.-L., Ylitalo, K., Vakkilainen, J., Nuotio, I., Valkonen, M., Lahdenperä, S., Viikari, J., & Taskinen, M.-R. (2002) · Annals of Medicine · doi:10.1080/078538902317338643 · Cited by 23
Wiemer, J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.12.2231 · Cited by 23
Mello, A. P. D. Q., da Silva, I. T., de Oliveira, A. S., Nunes, V. S., Abdalla, D. S. P., Gidlund, M., & Damasceno, N. R. T. (2010) · Lipids · doi:10.1007/s11745-010-3439-7 · Cited by 23
Chapman, M. J., & Bruckert, É. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05853-4 · Cited by 23
Self-citationSmall dense low-density lipoprotein-lowering agents
Alizadeh‐Fanalou, S., Nazarizadeh, A., Alian, F., Faraji, P., Sorori, B., & Khosravi, M. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0426 · Cited by 25
Insulin and lipoprotein metabolism with special reference to the diabetic state
TOMKIN, G. H., & Owens, D. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100303 · Cited by 22
Genetic, Metabolic, and Dietary Influences on the Atherogenic Lipoprotein Phenotype
Krauss, R. M. (1997) · KARGER eBooks · doi:10.1159/000059581 · Cited by 22
Ohta, T., Kakiuti, Y., Kurahara, K., Saku, K., Nagata, N., & Matsuda, I. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37283-7 · Cited by 22
Schwab, U., Sarkkinen, E., Lichtenstein, A. H., Li, Z., Ordovás, J. M., Schaefer, E. J., & Uusitupa, M. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600587 · Cited by 21
McEneny, J., McMaster, C., Trimble, E. R., & Young, I. S. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30125-5 · Cited by 20
Cavalcante, M. F., Kazuma, S. M., Bender, E. A., Adorne, M. D., Ullian, M., Veras, M. M., Saldiva, P. H. N., Maranhão, A. Q., Guterres, S. S., Pohlmann, A. R., et al. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.002 · Cited by 20
Prassl, R., Schuster, B., Laggner, P., Flamant, C., Nigon, F., & Chapman, M. J. (1998) · Biochemistry · doi:10.1021/bi971853f · Cited by 19
Self-citationCarbonneau, M., Cartron, E., Léger, C.-L., Senglat, C., & Descomps, B. (2002) · Free Radical Research · doi:10.1080/10715760290006466 · Cited by 19
Suzukawa, M., Ishikawa, T., Yoshida, H., HOSOAI, K., Nishio, E., Yamashita, T., Nakamura, H., Hashizume, N., & Suzuki, K. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718403 · Cited by 19
Yamashita, S., Kawase, R., Nakaoka, H., Nakatani, K., Inagaki, M., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Sandoval, J. C., Masuda, D., Ohama, T., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.010 · Cited by 18
The oxidative stress hypothesis of atherosclerosis: cause or product?
Stehbens, W. E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1999.0801 · Cited by 18
Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD
Roob, J. M., Rabold, T., Hayn, M., Khoschsorur, G., Resch, U., Holzer, H., & Winklhofer‐Roob, B. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780128.x · Cited by 18
van Tits, L. J. H., Smilde, T. J., van Wissen, S., Graaf, J. D., Kastelein, J. J. P., & Stalenhoef, A. F. H. (2004) · Journal of Investigative Medicine · doi:10.1177/108155890405200333 · Cited by 17
Rajman, I., Lip, G. Y. H., Cramb, R., Maxwell, S. R. J., Zarifis, J., Beevers, D. G., & Kendall, M. J. (1996) · QJM · doi:10.1093/qjmed/89.10.771 · Cited by 16
Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation.
Sharma, S. B., & Garg, S. (2012) · PubMed · Cited by 15
Bos, G., Poortvliet, M. C., Scheffer, P. G., Dekker, J. M., Ocké, M. C., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Teerlink, T., & Heine, R. J. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602492 · Cited by 15
Clinical Use of a Carbohydrate-Restricted Diet to Treat the Dyslipidemia of the Metabolic Syndrome
Hickey, J. T., Hickey, L., Yancy, W. S., Hepburn, J., & Westman, E. C. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322716705 · Cited by 14
Castilho, L. N., Oliveira, H. C. F., Cazita, P. M., de Oliveira, A. C., Sesso, A., & Quintão, E. C. R. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00401-0 · Cited by 14
Akyol, Ö., Chiang, H., Burns, A. R., Yang, C.-Y., Woodside, D. G., Sawamura, T., Sánchez‐Quesada, J. L., Gotto, A. M., & Chen, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1649759 · Cited by 14
Viens, L., Athias, A., Lizard, G., Simard, G., Gueldry, S., Braschi, S., Gambert, P., Lallemant, C., & Lagrost, L. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37300-4 · Cited by 13
Lepage, S., Nigon, F., Bonnefont‐Rousselot, D., Assogba, U., Goulinet, S., Chancharme, L., Delattre, J., Bruckert, É., & Chapman, M. J. (2000) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1053/xv.2000.5588 · Cited by 13
Self-citationPrassl, R., & Laggner, P. (2012) · InTech eBooks · doi:10.5772/48145 · Cited by 14
Should We “RESPECT EPA” More Now? EPA and DHA for Cardiovascular Risk Reduction
Kelsey, M. D., & Pagidipati, N. J. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01972-w · Cited by 13
Ansquer, J.-C., Corda, C., Malicot, K. L., & Jessent, V. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.03.002 · Cited by 11
Anti-oxidant therapy for the treatment of coronary artery disease
Kendall, M. J., & Nuttall, S. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.11.1763 · Cited by 11
Comparison between High-PUFA and Low-PUFA Fats on Lipid Peroxidation and LDL Oxidation
Seppanen, C. M., Cho, H., & Csallany, A. S. (2013) · Food and Nutrition Sciences · doi:10.4236/fns.2013.45074 · Cited by 10
The oxidation hypothesis of atherosclerosis
Rajman, I., Kendall, M. J., & Cramb, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90721-8 · Cited by 10
Pirwany, I. R., Sattar, N. A., Greer, I. A., Packard, C. J., & Fleming, R. (2002) · Human Reproduction · doi:10.1093/humrep/17.3.825 · Cited by 9
Callow, J., Samra, J. S., & Frayn, K. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00261-x · Cited by 9
Yoon, Y., Song, J., Park, H., Park, K. U., & Kim, J. Q. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.076 · Cited by 9
Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis
Holvoet, P. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.5.527 · Cited by 9
Effects of phytosterol supplementation on lipoprotein subfractions and LDL particle quality
Machado, V. A., Santisteban, A. R. N., Martins, C. M., Damasceno, N. R. T., Fonseca, F. A. H., Neto, A. M. F., & Izar, M. C. D. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-61897-4 · Cited by 8
Lehofer, B., Golub, M., Kornmueller, K., Kriechbaum, M., Martínez, N., Nagy, G., Kohlbrecher, J., Amenitsch, H. W., Peters, J., & Prassl, R. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800149 · Cited by 8
Biological Importance of Low-Density-Lipoprotein Subfractions
O’Brien, R. C. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100304 · Cited by 8
Plasma LDL subtype distribution in patients with or without coronary stenosis
Öztaş, Y., Özdöl, Ç., & Karaca, L. (2011) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1008-1075 · Cited by 7
LDL-apheresis: questions for the future
Bruckert, É. (1999) · Transfusion Science · doi:10.1016/s0955-3886(98)00090-3 · Cited by 7
Low‐density lipoprotein subfraction profiles in dialysis patients
Bofinger, A., Westhuyzen, J., Saltissi, D., Morgan, C., & Healy, H. G. (1997) · Nephrology · doi:10.1111/j.1440-1797.1997.tb00211.x · Cited by 7
Low plasma vitamin A concentrations in familial combined hyperlipidemia
Ribalta, J., Laville, A., Girona, J., Vallvé, J.-C., & Masana, L. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2379 · Cited by 7
Orekhov, A. N. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673301236240311113807 · Cited by 6
Yasuda, G., Ando, D., Hirawa, N., & Umemura, S. (2010) · Renal Failure · doi:10.3109/0886022x.2010.486493 · Cited by 6
Ferguson, E. E. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90011-7 · Cited by 6
Heller, F., Descamps, O. S., Hondekijn, J.-C., & Desager, J. P. (2000) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(99)00065-5 · Cited by 6
Sialic acid and oxidizability of low density lipoprotein subfractions of hyperlipidemic patients
Barbosa, D. S., Maranhão, R. C., Araujo, F., Chang, Y. H., Hirata, M. H., & Abdalla, D. S. P. (1995) · Clinical Biochemistry · doi:10.1016/0009-9120(95)00024-4 · Cited by 6
Dyslipidemias and the secondary prevention of coronary heart disease
Rosenson, R. S., Frauenheim, W. A., & Tangney, C. (1994) · Disease-a-Month · doi:10.1016/0011-5029(94)90027-2 · Cited by 6
Glycemic Status and Lipid Profiles of Diabetics in Sokoto, Nigeria
Ladan, M. J., Umar, R., Hassan, S., & B.Shehu (2007) · Asian Journal of Biochemistry · doi:10.3923/ajb.2007.183.187 · Cited by 7
The role of fibric acid derivatives in the secondary prevention of coronary heart disease
Krakoff, J. A., Vela, B. S., & Brinton, E. A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0060-z · Cited by 5
LDL oxidation and LDL particle size in the development of atherosclerosis
Liu, M. (2002) · Työväentutkimus Vuosikirja · Cited by 5
The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease
Froyen, E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99894 · Cited by 4
Skoglund-Andersson, C., Karpe, F., Hellénius, M.-L., Regnström, J., Hamsten, A., & Tornvall, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01084.x · Cited by 4
Park, J. S., Park, J., Kim, C. S., Cho, M. H., Kim, H. J., Kim, J., Ahn, C. W., Kim, K. R., Soo, B., Lim, S. K., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.07.022 · Cited by 4
Nicolosi, R. J., Wilson, T. A., Romano, C. A., & Kritchevsky, D. (2003) · Nutrition Research · doi:10.1016/s0271-5317(02)00531-6 · Cited by 4
Aggressive medical therapy for the prevention and treatment of coronary artery disease.
Malloy, M., & Kane, J. (1997) · Advances in internal medicine · doi:10.1016/s0011-5029(98)90000-1 · Cited by 2
Desialylation of Low Density Lipoprotein -Metabolic Function versus Oxidative Damage ?
Schlüssel, E., & Elstner, E. F. (1996) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1996-5-617 · Cited by 3
Heller, F., Descamps, O. S., Hondekijn, J.-C., & Desager, J. P. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600623 · Cited by 3
Orekhov, A. N., Orekhov, N. A., & Sobenin, I. A. (2025) · Current Medicinal Chemistry · doi:10.2174/092986733215250325111534 · Cited by 2
Low-Density Lipoprotein Particle Size Distribution in Subjects with Coronary Artery Disease
Rhim, H.-Y., Kim, I.-S., Seung, K., Kang, D., Jun, D.-S., Jang, K.-Y., Park, J., Lee, S. Y., Hong, S.-J., & Choi, G.-B. (1998) · Korean Circulation Journal · doi:10.4070/kcj.1998.28.8.1253 · Cited by 2
Posadas‐Romero, C., Posadas‐Sánchez, R., Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Cardoso-Saldaña, G. C., Caracas-Portilla, N., & Mendoza-Peŕez, E. (2008) · PubMed · Cited by 2
Assessing Coronary Heart Disease Risk and Managing Lipids
Braun, L. T., & Rosenson, R. S. (2001) · The Nurse Practitioner · doi:10.1097/00006205-200112000-00005 · Cited by 2
Winkler, K. (2004) · Journal of Laboratory Medicine · doi:10.1515/labmed.2004.060 · Cited by 2
Metadata
- Authors
- Dejager, S., Bruckert, E., & Chapman, M.
- Affiliations
- Inserm (FR)
- ORCID
- Chapman, MJ
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1993-02
- Volume
- 34
- Issue
- 2
- Pages
- 295-308
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2135183362
- Cited by
- 237
- References
- 67
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- mixed dyslipidemia, LDL particle size, LDL oxidation, copper-induced oxidation, conjugated dienes, vitamin E, atherogenic lipoproteins, apolipoprotein B, coronary heart disease risk, dietary management, familial hypercholesterolemia
- MeSH terms
- Adult, Centrifugation, Density Gradient, Chemistry, Physical, Humans, Hyperlipidemia, Familial Combined, Lipid Peroxides, Lipoproteins, LDL, Male, Middle Aged, Oxidation-Reduction, Particle Size, Vitamin E, Lipoprotein(a), Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review